Locations:
Search IconSearch

Research

Leadless Pacemaker

Interim Results Unveiled from LEADLESS II Study of Leadless Pacemaker

Efficacy and safety end points met in 90 percent of patients

chemical structure of sacubitril

Sizing Up the First Two New Heart Failure Meds in a Decade

Emerging therapies act by neprilysin inhibition and heart rate reduction

PCSK9-690×380

PCSK9 Inhibitors Edge Closer to FDA Approval

A new option for patients who need more than statins

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Pushing the Envelope to Prevent Device-Related Infections

Pushing the Envelope to Prevent Device-Related Infections

One of the largest-ever device trials will assess antibiotic delivery system

ACC-690×380

Novel Anticoagulation System Fails to Best Bivalirudin in Setting of PCI

Allergic reactions doom factor IXa inhibitor and antidote

Cholesterol-690×380

HDL Function Appears to Control Cholesterol-Lowering Ability

Amount of HDL may be less important than previously thought

BackPage 17 of 17Next

Advertisement

Ad